SILO PHARMA, INC. Valuation Allowance, Amount (Deprecated 2013-01-31)
SILO PHARMA, INC. (SILO) had Valuation Allowance, Amount (Deprecated 2013-01-31) of $21.00 thousand as of 2011-12-31, per its 10-K filed 2013-03-05.
Discontinued › Notes
us-gaap:ValuationAllowanceAmount · last filed 2013-03-05
- 2011-12-31: Valuation Allowance, Amount (Deprecated 2013-01-31) $21.00K.
| Period end | Valuation Allowance, Amount (Deprecated 2013-01-31) |
|---|---|
| 2011-12-31 | $21.00K 10-K · filed 2013-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |